Articles database

Sensitivity and specificity of LDBio Aspergillus ICT lateral flow assay for diagnosing allergic bronchopulmonary aspergillosis in adult asthmatics.

Sehgal IS, Muthu V, Dhooria S, Prasad KT, Rudramurthy SM, Aggarwal AN, Garg M, Gangneux JP, Chakrabarti A, Agarwal R.

2024

Validation of diagnoses of liver disorders in users of systemic azole antifungal medication in Sweden.

Giunta DH, Karlsson P, Younus M, Berglind IA, Kieler H, Reutfors J.

2024

Spinal infection caused by Aspergillus flavus in a diabetic: a case report and literature review.

Li H, Pan H, Lei Y, Wang H, Li S, Xiao C.

2024

Comparative Analysis of the Clarus Aspergillus Galactomannan Enzyme Immunoassay Prototype for the Diagnosis of Invasive Pulmonary Aspergillosis in Bronchoalveolar Lavage Fluid

Sarah Sedik · Johannes Boyer · Matthias Egger · Karl Dichtl ·
Juergen Prattes · Florian Prüller · Martin Hoenigl

2024

Risk factors for invasive fungal infections after haematopoietic stem cell transplantation: a systematic review and meta-analysis

Li Biyun 1, Han Yahui 2, Li Yuanfang 1, Guo Xifeng 1, Wang Dao

2024

In vitro activity of olorofim against 507 filamentous fungi including antifungal drug-resistant strains at a tertiary laboratory in Australia: 2020-2023

Catriona L Halliday, Enoch Tay, Wendy Green, Derek Law, Ronald Lopez, Silvia Faris, Lauren Meehan, Emma Harvey, Mike Birch, Sharon C A Chen 

2024

What do we know About the Usefulness of 18F-FDG PET-CT for the Management of Invasive Fungal Infection? An International Survey

A. Gutiérrez‐Villanueva · J. Calderón‐Parra · A. Callejas‐Diaz · E. Muñez‐Rubio · K. Velásquez ·
A. Ramos‐Martínez · B. Rodríguez‐Alfonso · A. Fernández‐Cruz

2024

Unveiling the Cell Wall-Targeting Mechanisms and Multifaceted Virulence Modulation by a Eugenol Glycoconjugate against Aspergillus fumigatus: Insights from in vitro and in ovo Studies.

Gupta L, Verma S, Goswami L, Kamboj H, Sen P, Bhattacharya AK, Vijayaraghavan P.

2024

Allogeneic stem cell transplant recipients surviving at least 2 years without relapse: outcome and risk factors.

Grønvold BL, Ali MM, Myklebust TÅ, Lenartova A, Remberger M, Abrahamsen IW, Tjønnfjord GE, Myhre AE, Fløisand Y, Gedde-Dahl T.

2024

Six-year analysis of the pathogenic spectrum, risk factors, and prognosis of non-traumatic fungal keratitis in Northern China.

Wang Y, Chen H, Wang F, Dong Y.

2024